| 证券代码：603810 | 证券简称：丰山集团 | 公告编号：2026-013 | | --- | --- | --- | | 转债代码：113649 | 转债简称：丰山转债 | | 江苏丰山集团股份有限公司 关于可转债转股结果暨股份变动的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 累计转股情况：自"丰山转债"2023 年 1 月 3 日进入转股期，截至 2026 年 3 月 31 日，累计已有 422,460 张"丰山转债"转为公司股份，累计转股 金额 42,246,000 元，累计转股股数 3,076,243 股，累计转股股数占"丰山转债" 转股前公司已发行股份总额 162,293,880 股的 1.90%。 未转股可转债情况：截至 2026 年 3 月 31 日，尚未转股的"丰山转债" 金额为人民币 457,754,000 元，占"丰山转债"发行总额的 91.55%。 本季度转股情况：本季度，"丰山转债"转股金额为 44,000 元，因转 股形成的股份数量为 3,203 股。 一、可转债发行 ...

为优化公司投资收益结构，提升投资管理能力，江苏丰山集团股份有限公司 （以下简称"公司"）于 2026 年 2 月 3 日与其他各方共同签署了《慈溪卓源星 | 证券代码：603810 | 证券简称：丰山集团 | 公告编号：2026-012 | | --- | --- | --- | | 转债代码：113649 | 转债简称：丰山转债 | | 江苏丰山集团股份有限公司 关于参与认购创业投资基金的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： | 投资标的名称 | 慈溪卓源星渝二号创业投资基金合伙企业 | | | --- | --- | --- | | | （有限合伙） | | | 投资金额（万元） | 1,500 | | | 投资进展阶段 | 完成 交易要素变更 进展 | 终止 | | | 募集失败 未能完成备案登记 | | | | 提前终止 | | | | 发生重大变更 | | | | 其他：公司作为有限合伙人承担的风险敞 | | | | 口以投资额为限，本次投资无保本及最低收 | | ...

| 证券代码：603810 | 证券简称：丰山集团 | 公告编号：2026-011 | | --- | --- | --- | | 转债代码：113649 | 转债简称：丰山转债 | | 更正后： 江苏丰山集团股份有限公司 关于为全资子公司和控股子公司提供担保 进展的更正公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 江苏丰山集团股份有限公司（以下简称"公司"）于 2026 年 3 月 28 日在上 海证券交易所网站（www.sse.com.cn）披露了《关于为全资子公司和控股子公 司提供担保的进展公告》（公告编号：2026-010），经公司自查，发现公告中部分 内容有误，现更正如下： 更正前： 一、担保情况概述 （一）担保的基本情况 为满足丰山生化、丰山全诺资金需要，近日江苏丰山集团股份有限公司（以 下简称"公司"）签署的担保合同情况如下： 1、公司与中信银行股份有限公司盐城分行签订《保证合同》，为丰山生化与 中信银行股份有限公司盐城分行形成的债务提供 3,000 万元的连带责任保证担 保。 2、公司与兴业银行股份有限 ...

| 证券代码：603810 | 证券简称：丰山集团 | 公告编号：2026-010 | | --- | --- | --- | | 转债代码：113649 | 转债简称：丰山转债 | | | 被担保人名称 | | | 实际为其提供的 | | 是否在前 | 本次担保 | | --- | --- | --- | --- | --- | --- | --- | | | 本次担保金额 | | 担保余额（不含本 | | 期预计额 | 是否有反 | | | | | 次担保金额） | | 度内 | 担保 | | 江苏丰山生化科技有限公司（以下 简称"丰山生化"） | 3,000 | 万元 | 22,441.72 | 万元 | 是 | 否 | | 江苏丰山全诺新能源科技有限公 司（以下简称"丰山全诺"） | 万元 500 | | 1,264.21 | 万元 | 是 | 有 | 累计担保情况 | 对外担保逾期的累计金额（万元） | 0 | | --- | --- | | 截至本公告日上市公司及其控股 子公司对外担保总额（万元） | 62,825.92 | | 对外担保总额占上市公司最近一 期经审计净资产的比例（%） | 39. ...

Group 1 - The company has signed a guarantee contract with Huaxia Bank Yancheng Branch to provide a joint liability guarantee for its wholly-owned subsidiary, Jiangsu Fengshan Biochemical Technology Co., Ltd. (Fengshan Biochemical), to meet its funding needs [2] - The board of directors approved a guarantee limit of up to 935 million yuan for Fengshan Biochemical for the year 2025, which can be used in various forms such as guarantees, mortgages, and pledges [3] - The guarantee limit is valid for 12 months from the date of approval by the annual general meeting and can be recycled and adjusted among subsidiaries, with specific conditions for those with an asset-liability ratio exceeding 70% [3] Group 2 - The guarantee agreement includes a coverage of the principal debt of 5 million yuan along with interest, overdue interest, penalties, and other related costs incurred by the bank to realize the main debt [7] - The necessity of the guarantee is to support the operational plans of Fengshan Biochemical, ensuring funding needs and improving decision-making efficiency, which aligns with the company's long-term interests [7] - As of February 25, 2026, the total external guarantees provided by the company and its subsidiaries amounted to 584.12 million yuan, accounting for 37.10% of the latest audited net assets [7]

Summary of Key Points Core Viewpoint - Fengshan Group announced the approval of a guarantee limit of 131,800.00 million yuan for its subsidiaries at the 2024 annual shareholders' meeting [2]. Group 1: Guarantee Details - As of February 25, 2026, the total external guarantees provided by the company and its subsidiaries amount to 58,412.07 million yuan, all of which are guarantees for subsidiaries within the consolidated financial statements [2]. - The total guarantee amount represents 37.10% of the company's most recent audited net assets [2]. - The actual guarantee balance provided by the company for its subsidiaries is 24,512.07 million yuan, accounting for 15.57% of the most recent audited net assets attributable to shareholders of the listed company [2]. Group 2: Compliance and Status - The company and its subsidiaries do not have any overdue external guarantees [2].

| 证券代码：603810 | 证券简称：丰山集团 | 公告编号：2026-009 | | --- | --- | --- | | 转债代码：113649 | 转债简称：丰山转债 | | 江苏丰山集团股份有限公司 关于为全资子公司提供担保的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 担保对象及基本情况 | | | 次担保金额） | | 额度内 | 反担保 | | --- | --- | --- | --- | --- | --- | | 被担保人名称 江苏丰山生化科技 有限公司 | 本次担保金额 500.00 万元 | 实际为其提供的 担保余额（不含本 17972.90 | 万元 | 是否在前期预计 是 | 本次担保是否有 否 | 累计担保情况 | 对外担保逾期的累计金额（万元） | 0 | | --- | --- | | 截至本公告日上市公司及其控股 | 58,412.07 | | 子公司对外担保总额（万元） | | | 对外担保总额占上市公司最近一 期经审计净资产的比例（%） | 37.10 | ...

Core Viewpoint - Jiangsu Fengshan Group Co., Ltd. announced the resignation of its securities affairs representative, Liang Huiying, due to personal reasons, effective immediately upon submission of her resignation report [1]. Group 1 - The board of directors received Liang Huiying's resignation report and confirmed that she will no longer hold any position within the company after her resignation [1]. - Liang Huiying did not hold any shares in the company at the time of her resignation [1]. - The company expressed gratitude for Liang Huiying's diligent work during her tenure as the securities affairs representative [1]. Group 2 - The board will promptly appoint a qualified individual to take over the role of securities affairs representative in accordance with relevant regulations [1].

Group 1 - Jiangsu Fengshan Group Co., Ltd. announced the resignation of Ms. Liang Huiying as the securities affairs representative due to personal reasons, effective immediately upon delivery to the board of directors [1] - Following her resignation, Ms. Liang will no longer hold any position within the company [1]

Group 1 - The core point of the article is that Fengshan Group announced the resignation of its securities affairs representative, Liang Huiying, due to personal reasons, effective immediately upon delivery to the board of directors [2] Group 2 - Liang Huiying will no longer hold any position within the company following her resignation [2] - The resignation highlights potential changes in the company's governance structure [2] - The announcement was made on February 24, indicating the company's commitment to transparency in its operations [2]